A detailed history of Cranbrook Wealth Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Cranbrook Wealth Management, LLC holds 542 shares of VTRS stock, worth $6,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
542
Previous 542 -0.0%
Holding current value
$6,785
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$8.77 - $10.85 $298 - $368
34 Added 6.69%
542 $5,000
Q1 2023

Apr 20, 2023

SELL
$9.2 - $12.26 $110 - $147
-12 Reduced 2.31%
508 $4,000
Q4 2022

Feb 09, 2023

SELL
$8.72 - $11.56 $52 - $69
-6 Reduced 1.14%
520 $5,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $251 - $287
-19 Reduced 3.49%
526 $7,000
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $7,793 - $10,213
545 New
545 $10,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cranbrook Wealth Management, LLC Portfolio

Follow Cranbrook Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cranbrook Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cranbrook Wealth Management, LLC with notifications on news.